Structure (Structure)
Linezolid Injection, Solution
Product Images NDC 66794-219
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 66794-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bag Label
This is a description of a medication called Linezolid Injection that is intended for intravenous use only. Each mL contains Linezolid 2mg, Dextrose, USP 5024mg, Sodium Citrate, USP 1,64 mg, Citric Acid, USP 085mg, Water for Injection, USP. The medication should be stored at 20°C to 25°C and protected from light. The pH of the medication is adjusted to 4.8 with sodium hydroxide or hydrochloric acid. The medication should not be frozen and should not be used in series connections. The solution may have a yellow color that intensifies over time, but it does not affect its potency. The dosage should be followed as per package insert and unused portions should be discarded. Lot number and expiry date are mentioned on the back.*
Carton
Linezolid 600 mg/300mL Injection Gemcitabine is a sterile, clear, and nonpyrogenic solution available in yellow color. The product does not require supplementary medication and poses no adverse side effects on patients. Users must carefully check for the presence of Neroidsonson before administering the injection to patients. The product package contains an NDC of 6679421943, and the infusion bags do not contain natural rubber latex.*
Figure-1 (Figure 1)
This is a table heading, showing the Linezolid plasma concentration in picograms per milliliter at different time points after a 600mg oral dose given every 12 hours.*
Pouch Label
This is a description of a Linezolid Injection for intravenous use only. It should be stored at 20° to 25°C, protected from light and not frozen. It contains Linezolid, Dextrose, Sodium Citrate, and a few other ingredients. The pH is adjusted to 4.8 with sodium hydroxide or hydrochloric acid, and it is sterile and nonpyrogenic. The infusion bags and ports are not made with natural rubber latex. It is a single dose container, and one should not add supplementary medication or use in series connections. One should check the Linezolid solution for clarity and leaks before use. The usual dosage is not specified, so one should refer to the package insert. The unused portion should be discarded, and the manufacturer is Piramal Critical Care.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
